Tenofovir as a first line option for prophylaxis in a patient with hepatitis B virus associated nephrotic syndrome

2011, Número 3

Ann Hepatol 2011; 10 (3)

Unverdi S, Ceri M, Köklü S, Unverdi H, Koçak E, Duranay M

Cómo citar este artículo

Idioma: Ingles.
Referencias bibliográficas: 7
Paginas: 372-373
Archivo PDF: 23.31 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

Lai ASH, Lai KN. Viral nephropathy. Nat Clin Pract Nephrol 2006; 2: 254-62.
Khaira A, Upadhyay BK, Sharma A, et al. Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature. Clin Exp Nephrol 2009; 13: 373-7.
Sakallioglu O, Gok F, Kalman S, et al. Hepatitis B complicated focal segmental glomerulosclerosis. J Nephrol 2005; 18: 433-5.
Herberth J, Herberth Z, Abul-Ezz SR, et al. Hepatitis B infection as a possible cause of focal segmental glomerular sclerosis. Clin Nephrol 2006; 65: 380-4.
Takaki A, Nakatsuka A, Satou C, et al. A case of focal segmental glomerulosclerosis (FSGS) complicated with chronic hepatitis B and treated with steroid and LDL apheresis. Nippon Jinzo Gakkai Shi 2002; 44: 806-12.
Izzedine H, Massard J, Poynard T, et al. Lamivudine and HBV-associated nephropathy. Nephrol Dial Transplant 2006; 21: 828-9.
Lai MY, Yang WC, Lee SD, et al. Long-term lamivudine therapy is not reasonable for HBV-associated nephropathy. Nephrol Dial Transplant 2006; 21: 1740-1.